Diffusion Pharmaceuticals Inc. Gains 28.46%

Thu 14 May 20 at 05:30 PM
Diffusion Pharmaceuticals Inc. Gains 28.46%

Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ) jumped higher at $1.02, a gain of 28.5%. On Wed 13 May 20, DFFN:NASDAQ touched a New 2-Week Intraday High of $0.86. The stock appeared on our News Catalysts scanner on Mon 27 Apr 20 at 05:11 PM in the 'BIOTECH' category. From Wed 29 Apr 20, the stock recorded 70.00% Up Days and 63.64% Green Days

About Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ)

Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.

Share